Cancer ScreeningNCT07583693
HBM-Based Intervention on Cancer Screening
A study testing HBM-Based İntervention on Cancer Screening in people with Cancer Screening and Health Belief Model, run by Lokman Hekim University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to examine the effect of an intervention-consisting of a Health Belief Model-based educational session on the importance of early diagnosis and cancer screening, along with SMS-supported reminders-on the perceptions and attitudes toward cancer screening among women aged 30-70 who do not… Read more about this study
- Who is it for?
- Ages 30 to 70 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cancer Screening, Health Belief Model, Attitude
- What is being tested?
- HBM-Based İntervention on Cancer Screening
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 6 May 2026to 6 Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 70 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Being female
- Being between the ages of 30 and 70
- Being able to communicate in Turkish
- Not having undergone regular cancer screenings
Who cannot join
- Having a previous diagnosis of any type of cancer
- Being under medical follow-up for suspected cancer
- Having cognitive impairment that prevents effective communication
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Lokman Hekim Universty
Ankara, Ankara, 06510
Nurbanu Odacı, +90 444 8548, nur_banu_odaci@hotmail.com
About this study
Official title: The Effect of Health Belief Model-Based Intervention on Women's Perceptions and Attitudes Toward Cancer Screening: A Quasi-Experimental Study
The aim of this study is to examine the effect of an intervention-consisting of a Health Belief Model-based educational session on the importance of early diagnosis and cancer screening, along with SMS-supported reminders-on the perceptions and attitudes toward cancer screening among women aged 30-70 who do not undergo regular screenings. The study will be conducted in two family centers, which will be assigned to intervention and control groups using a lottery method. The intervention group will receive a single-session group education, followed by weekly SMS reminders encouraging screening for two weeks. The control group will receive no additional intervention and will continue with standard care. Data will be collected simultaneously from both groups at three points: before the education, immediately after the education, and one month post-intervention.
- Conditions
- Cancer Screening, Health Belief Model, Attitude, Perception
- Being tested
- HBM-Based İntervention on Cancer Screening
- Keywords
- cancer screening, Health Belief Model, Attitude, Perception
- Medical subject headings
- Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HBM-Based İntervention on Cancer ScreeningBehavioural
The intervention group will receive a single-session group education lasting 45 minutes. The educational session will be supported by visual presentations, demonstrations on anatomical models, question-and-answer sessions, and group discussions. The curriculum covers the importance of early diagnosis and specific screening methods for breast, cervical, and colorectal cancers. Following the session, participants will receive motivational SMS reminders once a week for two consecutive weeks. These text messages will include motivational phrases to encourage screening attendance, as well as phone numbers and links for scheduling free screening appointments.
| Study group | Role | What they receive |
|---|---|---|
| HBM-Based İntervention on Cancer Screening | Experimental | Not described Receives: Behavioral: HBM-Based İntervention on Cancer Screening |
| Control Group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attitudes Toward Cancer Screening as measured by the Attitudes Toward Cancer Screening Scale
Measured: 1 month post-education
Perceived Severity of Cancer Subscale of the Cancer Screening Perception Scale
Measured: 1 month post-education
Perceived Susceptibility Subscale of the Cancer Screening Perception Scale
Measured: 1 month post-education
Perceived Benefits Subscale of the Cancer Screening Perception Scale
Measured: 1 month post-education
Perceived Barriers Subscale of the Cancer Screening Perception Scale
Measured: 1 month post-education
Cues to Action Subscale of the Cancer Screening Perception Scale
Measured: 1 month post-education
Secondary outcomes (1)
Cancer Screening Participation Rate
Measured: 1 month post-education
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 May 2026
- Study start6 May 2026 (estimated)
- Primary completion6 Jun 2026 (estimated)
- Study completion6 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer ScreeningStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Lokman Hekim University
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Nurbanu Odacı, Lokman Hekim University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07583693
- Sponsor's protocol ID
- LokmanHekimU-Hem-NO-04
- Status last verified
- May 2026
- First submitted
- 1 May 2026
- Last updated
- 13 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Health Belief Model-Based Intervention on Women's Perceptions and Attitudes Toward Cancer Screening: A Quasi-Experimental Study
- ClinicalTrials.gov ID
- NCT07583693
- Acronym / sponsor ID
- LokmanHekimU-Hem-NO-04
- Conditions
- Cancer Screening, Health Belief Model, Attitude, Perception
- Keywords
- cancer screening, Health Belief Model, Attitude, Perception
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Lokman Hekim UniversityOther government
- Study start
- 6 May 2026 (estimated)
- Primary completion
- 6 Jun 2026 (estimated)
- Study completion
- 6 Jun 2026 (estimated)
- First posted
- 13 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to examine the effect of an intervention-consisting of a Health Belief Model-based educational session on the importance of early diagnosis and cancer screening, along with SMS-supported reminders-on the perceptions and attitudes toward cancer screening among women aged 30-70 who do not undergo regular screenings. The study will be conducted in two family centers, which will be assigned to intervention and control groups using a lottery method. The intervention group will receive a single-session group education, followed by weekly SMS reminders encouraging screening for two weeks. The control group will receive no additional intervention and will continue with standard care. Data will be collected simultaneously from both groups at three points: before the education, immediately after the education, and one month post-intervention.
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| HBM-Based İntervention on Cancer Screening | Experimental | Behavioral: HBM-Based İntervention on Cancer Screening |
| Control Group | No intervention | – |
Who may qualify
- Ages
- 30 to 70 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Being female
- Being between the ages of 30 and 70
- Being able to communicate in Turkish
- Not having undergone regular cancer screenings
Key exclusion criteria (3 listed)
- Having a previous diagnosis of any type of cancer
- Being under medical follow-up for suspected cancer
- Having cognitive impairment that prevents effective communication
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HBM-Based İntervention on Cancer ScreeningThe intervention group will receive a single-session group education lasting 45 minutes. The educational session will be supported by visual presentations, demonstrations on anatomical models, question-and-answer sessions, and group discussions. The curriculum covers the importance of early diagnosis and specific screening methods for breast, cervical, and colorectal cancers. Following the session, participants will receive motivational SMS reminders once a week for two consecutive weeks. These text messages will include motivational phrases to encourage screening attendance, as well as phone numbers and links for scheduling free screening appointments. | Behavioural | HBM-Based İntervention on Cancer Screening |
Primary outcome
Attitudes Toward Cancer Screening as measured by the Attitudes Toward Cancer Screening Scale
Time frame: 1 month post-education
Perceived Severity of Cancer Subscale of the Cancer Screening Perception Scale
Time frame: 1 month post-education
Perceived Susceptibility Subscale of the Cancer Screening Perception Scale
Time frame: 1 month post-education
Perceived Benefits Subscale of the Cancer Screening Perception Scale
Time frame: 1 month post-education
Perceived Barriers Subscale of the Cancer Screening Perception Scale
Time frame: 1 month post-education
Cues to Action Subscale of the Cancer Screening Perception Scale
Time frame: 1 month post-education
1 secondary outcome
Cancer Screening Participation Rate
Time frame: 1 month post-education
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2026.
- Individual participant dataSharing planned: No
Related trials for Cancer Screening
RecruitingObservational study
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
Prostate Cancer, Prostate Biopsy
Not yet recruitingObservational study
Clinical Audit of Cervical Cytology Services in an Early Cancer Detection Unit
Cervical Intraepithelial Neoplasia, Uterine Cervical Neoplasms
Active, not recruitingObservational study
The BARCODE 1 Pilot Study
Prostate Cancer
Recruiting
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
Solid Tumor Cancer
Active, not recruitingObservational study
The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.
Prostate Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing HBM-Based İntervention on Cancer Screening in people with Cancer Screening and Health Belief Model, run by Lokman Hekim University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Nurbanu Odacı (+90 4448548, nur_banu_odaci@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attitudes Toward Cancer Screening as measured by the Attitudes Toward Cancer Screening Scale (time frame: 1 month post-education). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026; AzTrials last refreshed its copy on 28 Oct 2026.